META
Meta Platforms, Inc.
META's fundamentals are mixed, but it looks cheap: trading at 21x earnings, below its usual 27x. Analysts expect earnings growth, though they disagree widely on how much.
UPXI
Upexi, Inc.
There isn't enough reported data to score UPXI yet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UPXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Under pressure |
UPXI's revenue, profitability, cash flow and balance sheet are all currently under pressure.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
UPXI PE Valuation
UPXI has no meaningful PE right now: it lost money over the past year.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
UPXI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect UPXI's losses to shrink, with revenue growing.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the stronger earnings trend. Trailing diluted EPS is up 30% for META versus UPXI down 185%.
UPXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$20.99 | +$3.61 |
| Q4 2024 | -$22.12 | +$0.68 |
| Q3 2024 | -$23.28 | -$5.88 |
| Q2 2024 | -$23.13 | -$3.93 |
| Q1 2024 | -$24.60 | -$19.00 |
| Q4 2023 | -$22.80 | -$19.40 |
| Q3 2023 | -$17.40 | -$11.00 |
| Q2 2023 | -$19.20 | -$16.60 |
UPXI lost $20.99 per share over the past year, a smaller loss than the year before.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over UPXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META's operating margin was 20% last quarter, down 20 points from the same quarter a year ago, near the bottom of its range since 2019.
UPXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5M | -62% |
| Q2 2026 | $3.1M | -27% |
| Q1 2026 | $4.6M | +44% |
| Q4 2025 | $8.1M | +101% |
| Q3 2025 | $9.2M | +112% |
| Q1 2025 | $3.2M | -78% |
| Q4 2024 | $4M | -82% |
| Q3 2024 | $4.4M | -84% |
UPXI's revenue has slid since its 2023 peak: $3M last quarter, down 62% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2649% | +1901 points |
| Q2 2026 | -884% | -733 points |
| Q1 2026 | -2343% | -2230 points |
| Q4 2025 | -2178% | -2151 points |
| Q3 2025 | 748% | +779 points |
| Q2 2025 | -152% | N/A |
| Q1 2025 | -114% | -79 points |
| Q4 2024 | -27% | -19 points |
UPXI has the edge over META on profitability, with a higher operating margin.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over UPXI on cash generation, producing positive trailing cash flow while its opponent burns cash.
UPXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.2M | +$1.6M |
| Q2 2026 | -$3.7M | +$757.8K |
| Q1 2026 | -$4.8M | -$4M |
| Q4 2025 | -$2.7M | -$1.3M |
| Q3 2025 | -$9.8M | -$7.7M |
| Q2 2025 | -$4.5M | -283% |
| Q1 2025 | -$809.3K | +$171.3K |
| Q4 2024 | -$1.4M | -$1.2M |
UPXI has burned cash in most quarters: −$19M over the past year, against −$16M the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over UPXI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
UPXI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +105% | +68.9M shares |
| 1 year | +9957% | +133M shares |
| 3 years | +14820% | +133M shares |
| 5 years | +18388% | +134M shares |
| Available history | +18388% | +134M shares |
UPXI has 134M diluted shares, up 9957% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q2 2024 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
UPXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.3x | Elevated |
| Q4 2023 | 18.7x | High |
| Q2 2022 | -21.3x | Net Cash |
| Q1 2022 | -1.2x | Net Cash |
| Q4 2021 | -1.4x | Net Cash |
| Q3 2021 | -3.6x | Net Cash |
| Q2 2021 | -6.6x | Net Cash |
| Q1 2021 | 2.1x | Moderate |
UPXI's net debt is about 3.3 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
UPXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.6 | Oversold |
UPXI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
UPXI PE vs Communication Services Sector
UPXI has no meaningful PE right now: it lost money over the past year.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over UPXI on trend strength, trading above more of its moving averages.
UPXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.91 | 30% below |
| 20 week MA | $0.92 | 30% below |
| 50 week MA | $1.20 | 47% below |
| 100 week MA | $3.43 | 81% below |
| 200 week MA | $16.8 | 96% below |
UPXI is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over UPXI on returns for 2026, with the stronger performance.
UPXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $157.2 | $84.6 | -46% |
| 2022 | $84.6 | $62.0 | -27% |
| 2023 | $62.0 | $23.2 | -63% |
| 2024 | $23.2 | $3.86 | -83% |
| 2025 | $3.86 | $1.87 | -52% |
| 2026 YTD | $1.87 | $0.64 | -66% |
UPXI has finished every year since 2021 lower, and it's down 66% so far in 2026.